Error message

There was an error processing your request.

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Alpha Tau Medical Ltd (OQ:DRTS)

Business Focus: Shell Companies

Sector:  Financials Industry:  Holding Companies
 
See Regulatory Filings on SEC
Company Contact
Address: Kiryat Hamada 5
JERUSALEM 9777605
Tel: N/A
Website: https://www.alphatau.com
IR: See website
Key People
Uzi Sofer
Chairman of the Board, Chief Executive Officer
Raphi Levy
Chief Financial Officer
Amnon Gat
Chief Operations Officer
Ronen Segal
Chief Technology Officer
Robert Den
Chief Medical Officer
Itzhak Kelson
Chief Physics Officer
Business Overview
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Financial Overview
For the fiscal year ended 31 December 2023, Alpha Tau Medical Ltd revenues was not reported. Net loss decreased 14% to $29.2M. Lower net loss reflects Remeasurement of Warrants decrease from $3.8M (expense) to $0K, Interest from deposits increase from $1.8M to $4.8M (income), Stock-based Compensati decrease of 79% to $474K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.53 to -$0.42.